Search

Your search keyword '"Melissa G Collier"' showing total 2 results
Start Over Author "Melissa G Collier" Journal emerging infectious diseases
2 results on '"Melissa G Collier"'

1. Hepatitis E Virus among Persons Who Inject Drugs, San Diego, California, USA, 2009–2010

Author

Reena Mahajan, Melissa G. Collier, Saleem Kamili, Jan Drobeniuc, Jazmine Cuevas-Mota, Richard S. Garfein, and Eyasu Teshale

Subjects
hepatitis E virus, viruses, hepatitis E, injection drug use, seroprevalence, San Diego, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

Data about prevalence of hepatitis E virus infection in persons who inject drugs are limited. Among 18–40-year-old persons who inject drugs in California, USA, prevalence of antibodies against hepatitis E virus was 2.7%. This prevalence was associated with age but not with homelessness, incarceration, or high-risk sexual behavior.

Published
2013
Full Text
View/download PDF

2. Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010

Author

Jan Drobeniuc, Eyasu H. Teshale, Jazmine Cuevas-Mota, Reena Mahajan, Richard S. Garfein, Saleem Kamili, and Melissa G. Collier

Subjects
Male, Epidemiology, lcsh:Medicine, medicine.disease_cause, Antibodies, Viral, California, Hepatitis E virus, injection drug use, Seroepidemiologic Studies, Prevalence, antibodies, Viral, Substance Abuse, Intravenous, biology, seroprevalence, Substance Abuse, Dispatch, Hepatitis E, Infectious Diseases, Sexual behavior, Medical Microbiology, Public Health and Health Services, Female, Antibody, Intravenous, persons who inject drugs, Microbiology (medical), Adult, IgG, Clinical Sciences, hepatitis E virus, Microbiology, Antibodies, Injection drug use, lcsh:Infectious and parasitic diseases, San Diego, medicine, Seroprevalence, Humans, lcsh:RC109-216, viruses, business.industry, lcsh:R, medicine.disease, Virology, Immunoglobulin G, Immunology, biology.protein, business, Hepatitis E virus infection
Abstract

Data about prevalence of hepatitis E virus infection in persons who inject drugs are limited. Among 18-40-year-old persons who inject drugs in California, USA, prevalence of antibodies against hepatitis E virus was 2.7%. This prevalence was associated with age but not with homelessness, incarceration, or high-risk sexual behavior.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results